Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade-Reference-Cited by-同舟云学术

Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade

Published:2021-02 Issue:2 Volume:39 Page:193-208.e10
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Srivastava Shivani,Furlan Scott N.^ORCID,Jaeger-Ruckstuhl Carla A.^ORCID,Sarvothama Megha,Berger Carolina,Smythe Kimberly S.^ORCID,Garrison Sarah M.,Specht Jennifer M.,Lee Sylvia M.,Amezquita Robert A.,Voillet Valentin,Muhunthan Vishaka,Yechan-Gunja Sushma,Pillai Smitha P.S.,Rader Christoph^ORCID,Houghton A. McGarry,Pierce Robert H.,Gottardo Raphael,Maloney David G.,Riddell Stanley R.^ORCID

Funder

Fred Hutchinson Cancer Research Center

National Institutes of Health

Juno Therapeutics

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference62 articles.

1. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity;Adusumilli;Sci. Transl. Med.,2014

2. Intravascular staining for discrimination of vascular and tissue leukocytes;Anderson;Nat. Protoc.,2014

3. Vascular permeability and drug delivery in cancers;Azzi;Front. Oncol.,2013